Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Ion exercises option to license sickle cell anemia Rx

Jan. 14, 1997

Canadian launch for antiobesity drug

Jan. 14, 1997

Genetics Institute reports new bone morphogenic protein

Jan. 14, 1997

Thomae reports agents for hypercholesterolemia

Jan. 14, 1997

Positive phase III results reported for SCF

Jan. 13, 1997

Millennium/Roche obesity collaboration results in another significant discovery

Jan. 13, 1997

New approach to obesity gene research at Lilly

Jan. 13, 1997

Pramlintide can be mixed with insulin

Jan. 10, 1997

Sugen reports efficacy of novel antidiabetic drugs at H&Q conference

Jan. 10, 1997

Harvard Scientific to present impotence abstract

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...